Tuesday, January 27, 2009

ICardiac's COMPAS Technology Validated In Peer Reviewed Publication Co-Authored By FDA And University Of Rochester

ICardiac's COMPAS Technology Validated In Peer Reviewed Publication Co-Authored By FDA And University Of Rochester
iCardiac Technologies, Inc., a leader in advanced cardiac safety biomarker development, today announced that Computers in Cardiology has published an article by authors from the University of Rochester and the FDA demonstrating the use of the Highly Automated QT technology in data analysis in Thorough QT studies.

Effects Of Urinary Tract Infection In Patients With Bladder Augmentation And Kidney Transplantation

Effects Of Urinary Tract Infection In Patients With Bladder Augmentation And Kidney Transplantation
UroToday.com - A study from Brazil evaluated kidney transplantation in relation to urinary tract infection and bladder augmentation. This study showed 23 children who had undergone bladder augmentation and then had renal transplantation were retrospectively compared to 42 controls matched for gender, age, race, donor type, weight, and immunosuppression protocol in regards to graft outcome.